Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - BioNexus Gene Lab Corp | bion_10k.htm |
| EX-21 - SUBSIDIARIES - BioNexus Gene Lab Corp | bion_ex21.htm |
| EX-31.2 - CERTIFICATION - BioNexus Gene Lab Corp | bion_ex312.htm |
| EX-31.1 - CERTIFICATION - BioNexus Gene Lab Corp | bion_ex311.htm |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officers of the registrant certify, to the best of their knowledge, that the registrant's Annual Report on Form 10-K for the fiscal year ended December 31, 2020 (the "Form 10-K") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in the Form 10-K, fairly presents, in all material respects, the financial condition and results of operations of the registrant.
|
| Bionexus Gene Lab Corporation | ||
|
|
|
|
|
| Dated: March 30, 2021 | By: | /s/ Chan Chong Wong | |
|
|
| Chan Chong Wong Chief Executive Officer and Director (Principal Executive Officer) |
|
|
|
|
|
|
|
|
|
|
|
|
| By: | /s/ Wei Li Leong |
|
|
|
| Wei Li Leong Chief Financial Officer (Principal Financial and Accounting Officer) |
|